Dusseldorf - Delayed Quote EUR
Dynavax Technologies Corp (DYF1.DU)
8.39
-0.29
(-3.39%)
As of 4:31:44 PM GMT+2. Market Open.
Loading Chart for DYF1.DU
- Previous Close
8.68 - Open
8.47 - Bid 8.22 x --
- Ask 8.28 x --
- Day's Range
8.39 - 8.47 - 52 Week Range
8.35 - 13.62 - Volume
0 - Avg. Volume
1 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: DYF1.DU
View MorePerformance Overview: DYF1.DU
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
DYF1.DU
31.23%
S&P 500 (^GSPC)
0.21%
1-Year Return
DYF1.DU
16.09%
S&P 500 (^GSPC)
12.34%
3-Year Return
DYF1.DU
5.92%
S&P 500 (^GSPC)
46.47%
5-Year Return
DYF1.DU
42.57%
S&P 500 (^GSPC)
106.62%
Compare To: DYF1.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
8.39
-3.39%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.1300
-0.31%
Mkt Cap 4.673M
Industry Drug Manufacturers—Specialty & Generic
Statistics: DYF1.DU
View MoreValuation Measures
As of 5/13/2025
Market Cap
1.04B
Enterprise Value
702.84M
Trailing P/E
--
Forward P/E
27.55
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.32
Price/Book (mrq)
2.18
Enterprise Value/Revenue
2.65
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--